- •Incidence and prevalence were combined across 4 continents and 15 countries.
- •Incidence estimates were similar across regions; prevalence was more variable.
- •Prevalence of pediatric MS was found to be lowest in the Asia region.
- •Lack of estimates from other large regions (e.g. Africa, Russia, and Australia).
Multiple sclerosis (MS) is a debilitating immune disease leading to demyelination, neurodegeneration, and chronic inflammation of the central nervous system. Pediatric MS is a rare form of the disease and effects approximately 2–10% of individuals with MS. Diagnostic criteria and therapies are continuously evolving, thus it is imperative to further understand the epidemiology and subsequently global and regional disease burden of pediatric MS. Our objective was to conduct a systematic literature review and meta-analysis to assess the incidence and prevalence of pediatric MS globally. Subgroup analyses were also conducted by region and diagnostic criteria used to ascertain cases.
A systematic literature review was conducted using searches run in EMBASE and MEDLINE. A hand search was also conducted, and the bibliographies of any relevant articles were reviewed for any studies potentially not captured by the databases. A random effects model was used to combine epidemiological estimates across studies. Subgroup analyses by region and diagnostic criteria were performed in instances when three or more studies were available for analyses.
A total of 2,965 publications were identified, of which 187 were eligible for full-text screening. A total of 21 full-text articles met the eligibility criteria and were included for data extraction, with 18 studies included for meta-analysis. Regional epidemiologic estimates were obtained for North America, Europe, Middle East, and Asia. Country specific data was available for Canada, United States, Germany, Iceland, Netherlands, Sardinia, Slovenia, UAE/Abu Dhabi, Iran, Israel, Jordan, Kuwait, Tunisia, Taiwan, and Japan. Thirteen studies representing 12 countries reported incidence of pediatric MS. Overall incidence ranged from 0.05 to 2.85 and pooled global incidence was calculated to be 0.87 (95% CI: 0.35–1.40) per 100,000 individuals annually. Ten studies representing 10 countries reported on the prevalence of pediatric MS. Overall prevalence ranged from 0.69 to 26.92 per 100,000 individuals and pooled global prevalence was calculated to be 8.11 (95% CI: 2.28–13.93) per 100,000 people.
To our knowledge, this is the first meta-analysis conducted to provide pooled estimates of incidence and prevalence estimates of pediatric MS globally. In general, incidence estimates were similar across regions; however, prevalence was found to be more variable. Noticeable gaps in evidence include a lack of pediatric MS estimates from other large regions of the world such as Africa, South America, Russia, and Australia. Moreover, there is a need for more population-based studies using the most up to date diagnostic criteria.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Multiple Sclerosis and Related Disorders
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- Pathogenesis of pediatric multiple sclerosis.J. Child Neurol. 2012; 27: 1394-1407
- Defining the clinical course of multiple sclerosis: the 2013 revisions.Neurology. 2014; 83: 278-286
- Pediatric multiple sclerosis: updates in epidemiology, clinical features and management.Neurodegener. Dis. Manag. 2016; 6: 3-7
- The role of puberty and adolescence in the pathobiology of pediatric multiple sclerosis.Mult. Scler. Demyelinating Disord. 2018; 3: 2
- Multiple sclerosis: pathology, diagnosis and treatments.Exp. Ther. Med. 2017; 13: 3163-3166
- Vitamin D and multiple sclerosis: a comprehensive review.Neurol. Ther. 2018; 7: 59-85
- Examining the contributions of environmental quality to pediatric multiple sclerosis.Mult. Scler. Relat. Disord. 2017; 18: 164-169
- Paediatric multiple sclerosis: update on diagnostic criteria, imaging, histopathology and treatment choices.Curr. Neurol. Neurosci. Rep. 2016; 16 (68-68)
- Multiple sclerosis in children: an update on clinical diagnosis, therapeutic strategies, and research.Lancet Neurol. 2014; 13: 936-948
- Consensus definitions proposed for pediatric multiple sclerosis and related disorders.Neurology. 2007; 68: S7
- Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria.Ann. Neurol. 2011; 69: 292-302
- Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria.Lancet Neurol. 2018; 17: 162-173
- A Review of available treatments, clinical evidence, and guidelines for diagnosis and treatment of pediatric multiple sclerosis in the United States.J. Child Neurol. 2019; 34: 612-620
- Global, regional, and national burden of multiple sclerosis 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016.Lancet Neurol. 2019; 18: 269-285
- Pediatric multiple sclerosis: a review.BMC Neurol. 2018; 18 (27-27)
- Epidemiology of pediatric-onset multiple sclerosis: a systematic review of the literature.J. Child Neurol. 2019; 34: 705-712
- The PG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.PLoS Med. 2009; 6e1000097
- Study Quality Assessment Tools. 2019; (Web site.) (PublishedAccessed)
- The Hartung-Knapp-Sidik-Jonkman method for random effects meta-analysis is straightforward and considerably outperforms the standard DerSimonian-Laird method.BMC Med. Res. Methodol. 2014; 14: 25
- Measuring inconsistency in meta-analyses.BMJ. 2003; 327: 557-560
- Epidemiology of pediatric multiple sclerosis, neuromyelitis optica, and optic neuritis in Taiwan.J. Neurol. 2019;
- Multiple sclerosis in pediatric patients in Slovenia.Mult. Scler. Relat. Disord. 2018; 20: 194-198
- Pediatric-onset multiple sclerosis and other acquired demyelinating syndromes of the central nervous system in Denmark during 1977-2015: a nationwide population-based incidence study.Mult. Scler. J. 2018; 24: 1077-1086
- Epidemiological and clinical characteristics of multiple sclerosis in paediatric population in Slovenia: a descriptive nation-wide study.Mult. Scler. Relat. Disord. 2017; 18: 56-59
- Implications of the International Paediatric Multiple Sclerosis Study Group consensus criteria for paediatric acute disseminated encephalomyelitis: a nationwide validation study.Dev. Med. Child Neurol. 2018; 60: 1123-1131
- International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions.Mult. Scler. J. 2013; 19: 1261-1267
- Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”.Ann. Neurol. 2005; 58: 840-846
- Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis.Ann. Neurol. 2001; 50: 121-127
- New diagnostic criteria for multiple sclerosis: guidelines for research protocols.Ann. Neurol. 1983; 13: 227-231
- Incidence of pediatric neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody-associated disease in Denmark 2008-2018: a nationwide, population-based cohort study.Mult. Scler. Relat. Disord. 2019; 33: 162-167
- Multiple sclerosis in children and adolescents: incidence and clinical picture - new insights from the nationwide German surveillance (2009-2011).Eur. J. Neurol. 2014; 21: 654-659
- Incidence of acquired CNS demyelinating syndromes in a multiethnic cohort of children.Neurology. 2011; 77: 1143-1148
- Pediatric multiple sclerosis in Tunisia: a retrospective study over 11 years.Biomed. Res. Int. 2017; (no pagination)): 2017
- Epidemiology of multiple sclerosis in the pediatric population of Sardinia, Italy.Eur. J. Pediatr. 2016; 175: 19-29
- Incidence of acquired demyelinating syndromes of the CNS in Dutch children: a nationwide study.J. Neurol. 2012; 259: 1929-1935
- Pediatric Multiple Sclerosis in the United Arab Emirates: characteristics From a Multicenter Study and Global Comparison.J. Child Neurol. 2018; 33: 422-427
- Relative Incidence of Inherited White Matter Disorders in Childhood to Acquired Pediatric Demyelinating Disorders.Semin. Pediatr. Neurol. 2012; 19: 219-223
- Incidence and prevalence of MS in children: a population-based study in Ontario, Canada.Neurology. 2018; 91: E1579-E1590
- A nationwide survey of pediatric acquired demyelinating syndromes in Japan.Neurology. 2016; 87: 2006-2015
- Multiple sclerosis in Israeli children: incidence, an clinical, cerebrospinal fluid and magnetic resonance imaging findings.Isr. Med. Assoc. J. 2012; 14: 234-239
- Pediatric multiple sclerosis and its familial recurrence: a population based study (1999-2017).Mult. Scler. Relat. Disord. 2019; 36101377
- Clinical study of childhood acute disseminated encephalomyelitis, multiple sclerosis, and acute transverse myelitis in Fukuoka Prefecture, Japan.Brain Dev. 2010; 32: 454-462
- Multiple sclerosis prevalence in the United States commercially insured population.Neurology. 2016; 86: 1014
- Atlas of MS 2013: Mapping Multiple Sclerosis Around the World.MS International Federation, 2013
- Geographical variations in sex ratio trends over time in multiple sclerosis.PLoS ONE. 2012; 7 (e48078-e48078)
- Temporal trends in multiple sclerosis prevalence and incidence in a large population.Neurology. 2018; 90: e1435
- Incidence and outcome of acquired demyelinating syndromes in Dutch children: update of a nationwide and prospective study.J. Neurol. 2018; 265: 1310-1319
- Consensus definitions for pediatric MS and other demyelinating disorders in childhood.Neurology. 2016; 87: S8
- Paediatric multiple sclerosis and acute disseminated encephalomyelitis in Germany: results of a nationwide survey.Eur. J. Pediatr. 2007; 166: 405-412
- Nationwide incidence of acquired central nervous system demyelination in Icelandic children.Pediatr. Neurol. 2015; 53: 503-507
- Early onset multiple sclerosis in Jordan: a retrospective analysis.J. Pediatr. Neurol. 2006; 4: 155-160
- Incidence and prevalence of pediatric onset multiple sclerosis in Kuwait: 1994-2013.J. Neurol. Sci. 2015; 353: 107-110
Published online: June 04, 2020
Accepted: June 1, 2020
Received in revised form: May 8, 2020
Received: March 24, 2020
© 2020 Elsevier B.V. All rights reserved.